Jiangxi Sanxin Medtec Co.,Ltd. (SHE:300453)
China · Delayed Price · Currency is CNY 9.28
+0.17 (1.87%)
Sep 14, 2026, 3:04 PM CST
Jiangxi Sanxin Medtec Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 1,716 | 1,640 | 1,500 | 1,300 | 1,336 | 1,164 |
Revenue Growth | 8.97% | 9.31% | 15.41% | -2.69% | 14.75% | 23.81% |
Gross Profit Gross Profit Growth | 621.99 | 584.1 | 528.39 | 452.79 | 449.49 | 400.33 |
Operating Income Operating Income Growth | 310.34 | 295.12 | 263.22 | 221.96 | 203.91 | 186.98 |
Net Income Net Income Growth | 281.94 | 264.94 | 227.4 | 206.63 | 184.63 | 155.91 |
Earnings Per Share EPS Growth | 0.54 | 0.51 | 0.44 | 0.40 | 0.36 | 0.30 |
EPS Growth | 19.26% | 16.08% | 10.64% | 11.13% | 18.00% | 35.56% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Medical Device Industry Medical Device Industry Growth | 1,632 | 1,495 | 1,293 | 1,332 | 1,159 |
Other Business Other Business Growth | 8.08 | 5.43 | 7.05 | 4.14 | 5.76 |
Total Total Growth | 1,640 | 1,500 | 1,300 | 1,336 | 1,164 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 524.47 | 621.27 | 521.5 | 373.13 | 361 | 250.8 |
Total Debt Total Debt Growth | 244.64 | 230.03 | 237.43 | 203.19 | 129.08 | 42.05 |
Net Cash (Debt) Net Cash Growth | 279.83 | 391.24 | 284.06 | 169.94 | 231.92 | 208.75 |
Net Cash Growth | 15.73% | 37.73% | 67.16% | -26.73% | 11.10% | 120.64% |
Net Cash Per Share Net Cash Per Share Growth | 0.54 | 0.76 | 0.55 | 0.33 | 0.45 | 0.41 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 426.9 | 460.6 | 389.59 | 339.81 | 402.18 | 329.72 |
Capital Expenditures CapEx Growth | -231.51 | -241.87 | -217.54 | -287.47 | -210.55 | -174.8 |
Free Cash Flow Free Cash Flow Growth | 195.39 | 218.73 | 172.05 | 52.34 | 191.62 | 154.91 |
Free Cash Flow Growth | -5.90% | 27.13% | 228.72% | -72.69% | 23.70% | -11.36% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 36.24% | 35.61% | 35.22% | 34.83% | 33.64% | 34.38% |
Operating Margin | 18.08% | 17.99% | 17.54% | 17.07% | 15.26% | 16.06% |
Pretax Margin | 19.93% | 19.77% | 18.40% | 19.44% | 16.89% | 16.78% |
Profit Margin | 16.43% | 16.15% | 15.16% | 15.89% | 13.82% | 13.39% |
FCF Margin | 11.39% | 13.34% | 11.47% | 4.03% | 14.34% | 13.31% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.300 | 0.300 | 0.300 | 0.115 | 0.115 | 0.115 |
Dividend Per Share Growth | 0% | 0% | 159.97% | 0% | 0% | 12.58% |
Dividend Yield | 3.21% | 3.52% | 4.25% | 1.66% | 1.94% | 1.34% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 17.04 | 16.93 | 16.86 | 19.19 | 18.55 | 31.92 |
Forward PE | - | 112.28 | 112.28 | 112.28 | 112.28 | 112.28 |
P/FCF Ratio | 24.79 | 20.50 | 22.29 | 75.75 | 17.88 | 32.13 |
PS Ratio | 2.82 | 2.73 | 2.56 | 3.05 | 2.56 | 4.27 |